Vivos Therapeutics, Inc. (VVOS) Financials
VVOS Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-09-30 | 10.3 million | 10.3 million |
2023-06-30 | 13.7 million | 11.6 million |
2023-03-31 | 17.1 million | 10.1 million |
2022-12-31 | 13.7 million | 8.9 million |
VVOS Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-09-30 | -3.0 million | 189000 |
2023-06-30 | -3.1 million | 459000 |
2023-03-31 | -3.8 million | 306000 |
2022-12-31 | -3.2 million | 775000 |
VVOS Net Income
No data available :(
VVOS Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-09-30 | 988000 | - | 2.1 million |
2023-06-30 | 3.9 million | - | 2.2 million |
2023-03-31 | 7.0 million | - | 2.3 million |
2022-12-31 | 3.5 million | - | 2.4 million |
VVOS Shares Outstanding
VVOS Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-09-30 | 154000 | 100000 | 4.6 million | 641000 |
2023-06-30 | 245000 | 100000 | 5.9 million | 590000 |
2023-03-31 | 239000 | - | 6.5 million | 630000 |
2022-12-31 | 200000 | - | 6.9 million | 1.4 million |
VVOS Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-09-30 | 3.3 million | 1.4 million |
2023-06-30 | 3.4 million | 1.3 million |
2023-03-31 | 3.9 million | 1.5 million |
2022-12-31 | 4.0 million | 1.6 million |
VVOS
Price: $2.60
52 week price:
Earnings Per Share: -11.14 USD
P/E Ratio: -0.38
Exchange: NCM
Sector: Healthcare
Industry: Medical Devices
Volume: 77800
Market Capitalization: 7.9 million